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Cervical cancer is caused by persistent infection with high-risk human
papillomavirus (HR-HPV). Conventional human papillomavirus (HPV) testing
requires cervical sampling. However, vaginal and urine self-sampling methods are
more acceptable for patients and result in increased participation when they are
available in screening programs. In this context, we have developed a non-invasive
screening method via the detection of HPV DNA in urine samples.
Purpose
To compare HPV viral loads and genotypes in paired cervical and urine samples,
and to assess correlation between virological and cytological results in women
seeking gynecological consultation.
Methods
Paired urine and cervical specimens were collected and analyzed from 230 of 245
women participating in the previously described prospective PapU study. HPV
DNA detection and quantification were performed using a real-time PCR method
with short fragment PCR primers. Genotyping was carried out using the INNO-
LiPA HPV genotyping assay.
Results
The prevalence of HPV in the 230 paired urine and cervical smear samples was 42
and 49 %, respectively. Overall agreement for HPV positivity and negativity
between the paired samples was 90 % (κ = 0.80). High HPV viral load in both
cervical and urine samples was associated with cytological abnormalities. HPV-
positive women were mostly infected with HR-HPV types. The agreement between
high- and low-risk HPV (LR-HPV) detection in both samples was 97 % (κ = 0.95 for
HR-HPV and κ = 0.97 for LR-HPV).
Conclusions
High concordance rates for HPV-DNA quantification and high/low-risk HPV
genotyping in paired urine/cervical samples suggest that urinary HPV DNA testing
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